Wednesday, June 10, 2026
🇺🇸 FDA

biotech · Breast Cancer · Pleural carcinosis · SANA

Sana Biotechnology

Sana Biotechnology trial registry — 20 ClinicalTrials.gov studies with program phase, status, and indication context.

Website Investor relations
188 E Blaine St, Suite 400, Seattle, Washington 98102, US HQ
2018 Founded
265 Employees
Public company Type
SANA · NYSE Ticker
Company details
Status
Public
HQ
188 E Blaine St, Suite 400, Seattle, Washington 98102, US
Founded
2018
Employees
265
Programs
19
Drugs
21
Patents
136
Official website ↗ All projects Drug pipeline Patents News & analysis
Intelligence · Clinical Trials

Sana Biotechnology clinical trials

Registry index of 20 ClinicalTrials.gov studies linked to Sana Biotechnology programs — each row shows trial ID, program name, phase, status, and indication.

Sana Biotechnology trial registry — 20 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

8 updates

Latest clinical program signals indexed for Sana Biotechnology.

  1. TARGET2020 — Approved

    Clinical update

  2. GN-002 — Phase 2

    Clinical update

  3. Sodio ioduro (I131) Curium Netherlands 37-740... — Phase 3

    Clinical update

  4. TREAT LMNA — Phase 2

    Clinical update

  5. PITAC_ MaPEPi — Phase 2

    Clinical update

  6. ABC2 — Phase 2

    Clinical update

  7. Sana Device (Control) — Unknown

    Clinical update

  8. Myocet (Non-pegylated liposomal doxorubicin (NPLD)) — Phase 2

    Clinical update

Trial registry

20 studies

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.